— Know what they know.
Not Investment Advice
Also trades as: 0J9P.L (LSE) · $vol 0M

INCY NASDAQ

Incyte Corporation
1W: -0.2% 1M: +0.7% 3M: -3.9% YTD: -4.0% 1Y: +49.2% 3Y: +50.6% 5Y: +17.9%
$97.16
-0.25 (-0.26%)
 
Weekly Expected Move ±3.7%
$88 $92 $95 $99 $102
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 55 · $19.4B mcap · 198M float · 0.766% daily turnover · Short 64% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
60.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 71.3%  ·  5Y Avg: 105.0%
Cost Advantage
63
Intangibles
50
Switching Cost
61
Network Effect
82
Scale
54
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. INCY has a Narrow competitive edge (60.8/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 71.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$90
Low
$94
Avg Target
$99
High
Based on 2 analysts since Apr 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 23Hold: 19Sell: 2Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$94.50
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-21 Bernstein Initiated $99 +1.6% $97.41
2026-04-29 Oppenheimer $82 $90 +8 -7.9% $97.74
2026-02-18 Barclays $116 $117 +1 +15.7% $101.16
2026-02-11 Morgan Stanley $92 $102 +10 +3.6% $98.45
2026-02-11 Stifel Nicolaus Stephen Willey $119 $120 +1 +19.9% $100.05
2026-02-06 Piper Sandler Allison Bratzel $102 $110 +8 +7.0% $102.76
2026-02-05 H.C. Wainwright Initiated $135 +31.6% $102.60
2026-02-04 Barclays $115 $116 +1 +14.9% $100.92
2026-01-20 Wells Fargo $116 $107 -9 +0.7% $106.21
2026-01-08 Goldman Sachs $60 $90 +30 -18.6% $110.57
2026-01-05 Stifel Nicolaus Stephen Willey Initiated $119 +16.9% $101.79
2025-12-24 Truist Financial Srikripa Devarakonda $93 $103 +10 +2.1% $100.91
2025-12-08 Morgan Stanley $76 $92 +16 -4.6% $96.47
2025-12-08 Wells Fargo Derek Archila $97 $116 +19 +13.1% $102.52
2025-12-08 Mizuho Securities Salim Syed Initiated $121 +18.0% $102.52
2025-11-24 Barclays $101 $115 +14 +12.7% $102.06
2025-11-04 Piper Sandler Allison Bratzel Initiated $102 -0.3% $102.35
2025-10-29 Truist Financial Initiated $93 +2.9% $90.35
2025-10-29 RBC Capital $67 $84 +17 -8.3% $91.65
2025-10-29 Wells Fargo Derek Archila $75 $97 +22 +5.4% $92.02
2025-10-29 Barclays Peter Lawson Initiated $101 +10.2% $91.65
2025-07-30 UBS Initiated $68 -12.3% $77.55
2025-06-23 RBC Capital $66 $67 +1 -0.4% $67.26
2025-03-18 Guggenheim $104 $92 -12 +53.3% $60.00
2024-10-30 Seaport Global Aaron Kessler Initiated $200 +174.0% $73.00
2024-10-30 Oppenheimer Jay Olson $81 $82 +1 +11.4% $73.60
2024-10-30 Citigroup David Lebowitz $92 $97 +5 +31.8% $73.60
2024-10-29 Jefferies Kelly Shi Initiated $84 +14.1% $73.60
2024-10-29 Bank of America Securities Tazeen Ahmad $68 $90 +22 +22.3% $73.60
2024-09-30 Wolfe Research Andy Chen Initiated $84 +27.1% $66.10
2024-09-16 Bank of America Securities Tazeen Ahmad Initiated $68 +7.0% $63.56
2024-09-16 Goldman Sachs Salveen Richter $136 $60 -76 -5.6% $63.56
2024-08-18 Citigroup David Lebowitz Initiated $92 +48.0% $62.16
2024-07-31 RBC Capital Brian Abrahams Initiated $66 +0.5% $65.70
2024-07-26 Oppenheimer Jay Olson $98 $81 -17 +18.1% $68.57
2024-07-02 BMO Capital Evan Seigerman $52 $48 -4 -21.1% $60.87
2024-05-23 Deutsche Bank James Shin Initiated $55 -5.5% $58.20
2024-04-30 BMO Capital Evan David Seigerman $75 $52 -23 -0.1% $52.05
2024-04-25 Argus Research Jasper Hellweg Initiated $70 +38.7% $50.48
2023-02-08 Cowen & Co. Initiated $100 +24.4% $80.38
2023-01-03 Wells Fargo Initiated $75 -5.9% $79.73
2022-08-15 Oppenheimer Jay Olson $109 $98 -11 +32.5% $73.99
2022-07-20 Leerink Partners Initiated $63 -22.6% $81.36
2022-04-20 Morgan Stanley Initiated $76 -3.7% $78.94
2022-02-07 BMO Capital Evan Seigerman Initiated $75 +7.0% $70.07
2022-01-02 Guggenheim Michael Schmidt Initiated $104 +40.6% $73.97
2021-11-23 Goldman Sachs Salveen Richter Initiated $136 +103.8% $66.74
2021-11-02 Oppenheimer Jay Olson Initiated $109 +63.2% $66.79
2021-10-14 Cantor Fitzgerald Alethia Young Initiated $79 +20.5% $65.56
2021-09-22 Ladenburg Thalmann & Co. Aydin Huseynov Initiated $89 +27.5% $69.78

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A
May 22, 2026
DCF
5
ROE
5
ROA
5
D/E
4
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. INCY receives an overall rating of A. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5), D/E (4/5). Areas of concern: P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 A+ A
2026-05-06 A A+
2026-04-28 B A
2026-04-28 A B
2026-03-16 A+ A
2026-02-11 A A+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

86 Grade A+
Profitability
94
Balance Sheet
98
Earnings Quality
73
Growth
76
Value
68
Momentum
92
Safety
100
Cash Flow
88
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. INCY scores highest in Safety (100/100) and lowest in Value (68/100). An overall grade of A+ places INCY among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
8.74
Safe Zone
Piotroski F-Score
8/9
Beneish M-Score
-2.41
Unlikely Manipulator
Ohlson O-Score
-12.21
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AAA
Score: 96.8/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 1.06x
Accruals: -1.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. INCY scores 8.74, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. INCY scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. INCY's score of -2.41 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. INCY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. INCY receives an estimated rating of AAA (score: 96.8/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). INCY's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
13.53x
PEG
0.01x
P/S
3.62x
P/B
3.49x
P/FCF
13.42x
P/OCF
12.83x
EV/EBITDA
8.53x
EV/Revenue
2.98x
EV/EBIT
8.98x
EV/FCF
11.00x
Earnings Yield
7.35%
FCF Yield
7.45%
Shareholder Yield
0.13%
Graham Number
$62.38
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 13.5x earnings, INCY trades at a reasonable valuation. An earnings yield of 7.4% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $62.38 per share, 56% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.807
NI / EBT
×
Interest Burden
0.999
EBT / EBIT
×
EBIT Margin
0.331
EBIT / Rev
×
Asset Turnover
0.865
Rev / Assets
×
Equity Multiplier
1.440
Assets / Equity
=
ROE
33.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. INCY's ROE of 33.2% is driven by Asset Turnover (0.865), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
68.85%
Fair P/E
146.21x
Intrinsic Value
$1012.13
Price/Value
0.09x
Margin of Safety
90.70%
Premium
-90.70%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with INCY's realized 68.9% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $1012.13, INCY appears undervalued with a 91% margin of safety. The adjusted fair P/E of 146.2x compares to the current market P/E of 13.5x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$97.16
Median 1Y
$94.06
5th Pctile
$56.13
95th Pctile
$157.80
Ann. Volatility
31.7%
Analyst Target
$94.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
William J. Meury
Chief Executive Officer
$647,260 $27,509,657 $32,085,952
Mohamed Issa Head
utive Vice President and Head of U.S. Commercial
$690,411 $7,870,118 $10,592,782
Pablo J. Cagnoni
President and Global Head of Research and Development
$966,516 $4,952,378 $8,838,961
Hervé Hoppenot
Former President and Chief Executive Officer
$1,392,499 $1,971,975 $6,380,525
Steven H. Stein
Executive Vice President, Chief Medical Officer and Head of Late-stage Development
$835,067 $3,466,675 $6,304,172
Christiana Stamoulis Financial
ecutive Vice President and Chief Financial Officer
$520,839 $3,136,468 $4,936,550
Thomas Tray President,
dent, Chief Accounting Officer and Principal Financial Officer
$358,189 $305,897 $990,368

CEO Pay Ratio

66:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $32,085,952
Avg Employee Cost (SGA/emp): $483,898
Employees: 2,844

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,844
+8.7% YoY
Revenue / Employee
$1,807,750
Rev: $5,141,242,000
Profit / Employee
$452,409
NI: $1,286,650,000
SGA / Employee
$483,898
Avg labor cost proxy
R&D / Employee
$697,456
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 13.0% 20.5% 29.7% 29.2% 29.6% 27.5% 8.4% 8.0% 9.0% 10.4% 12.5% 15.6% 2.0% 0.7% 0.8% 0.5% 20.2% 27.5% 29.9% 33.2% 33.24%
ROA 9.7% 15.3% 22.3% 22.0% 22.3% 20.6% 6.3% 6.0% 6.8% 7.9% 9.5% 11.8% 1.5% 0.5% 0.5% 0.3% 14.2% 19.4% 20.7% 23.1% 23.09%
ROIC 45.2% 69.1% 72.3% 72.4% 77.3% 65.8% 32.9% 27.2% 24.8% 30.4% 29.7% 33.2% 0.6% -0.1% 0.6% 1.0% 51.5% 71.2% 63.2% 71.3% 71.27%
ROCE 13.9% 21.2% 14.0% 14.1% 15.5% 14.0% 11.4% 11.0% 12.0% 13.8% 15.1% 18.4% 6.4% 5.0% 8.4% 8.3% 33.3% 41.8% 30.6% 32.6% 32.63%
Gross Margin 93.3% 94.0% 93.8% 92.7% 93.2% 92.0% 92.2% 91.3% 91.3% 91.8% 91.5% 91.2% 91.1% 91.0% 91.1% 91.5% 92.1% 92.8% 92.0% 91.8% 91.79%
Operating Margin 22.0% 30.4% 13.9% 17.4% 28.6% 14.4% 10.1% 3.7% 21.1% 23.4% 20.3% 10.3% -45.7% 14.9% 25.2% 20.6% 25.6% 32.5% 25.5% 25.5% 25.47%
Net Margin 21.2% 22.4% 65.3% 5.2% 17.7% 13.7% 3.1% 2.7% 21.3% 18.6% 19.8% 19.2% -42.6% 9.4% 17.1% 15.0% 33.3% 31.1% 19.9% 23.8% 23.83%
EBITDA Margin 26.4% 27.6% 15.7% 12.0% 27.1% 20.2% 10.7% 8.8% 31.3% 27.8% 29.0% 29.3% -35.2% 15.8% 28.6% 24.4% 47.8% 37.1% 27.5% 28.9% 28.91%
FCF Margin 16.5% 18.7% 19.0% 19.6% 20.0% 21.3% 26.3% 16.2% 19.9% 15.7% 12.1% 21.0% -3.6% 0.4% 5.5% 6.5% 20.6% 24.9% 26.3% 27.1% 27.06%
OCF Margin 24.6% 25.5% 25.1% 24.4% 22.9% 24.1% 28.6% 18.7% 22.2% 17.5% 13.4% 21.8% -1.6% 2.5% 7.9% 8.7% 21.9% 26.0% 27.5% 28.3% 28.29%
ROE 3Y Avg snapshot only 14.23%
ROE 5Y Avg snapshot only 14.97%
ROA 3Y Avg snapshot only 10.65%
ROIC Economic snapshot only 23.01%
Cash ROA snapshot only 21.80%
Cash ROIC snapshot only 91.58%
CROIC snapshot only 87.60%
NOPAT Margin snapshot only 22.02%
Pretax Margin snapshot only 33.09%
R&D / Revenue snapshot only 39.39%
SGA / Revenue snapshot only 25.72%
SBC / Revenue snapshot only 3.55%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 55.38 28.59 17.18 18.98 17.98 17.05 53.01 50.26 38.33 30.74 23.76 17.37 135.93 398.53 418.09 564.21 15.54 14.37 15.72 13.60 13.527
P/S Ratio 6.87 5.25 5.46 5.68 5.12 4.49 5.32 4.70 4.00 3.62 3.84 3.44 3.43 3.18 3.22 2.72 2.95 3.55 3.93 3.63 3.621
P/B Ratio 7.16 5.85 4.32 4.70 4.51 3.96 4.13 3.73 3.21 2.99 2.74 2.49 2.55 2.49 3.96 3.48 3.93 4.96 3.91 3.77 3.488
P/FCF 41.57 28.13 28.66 29.07 25.55 21.02 20.24 29.07 20.13 23.09 31.62 16.37 -94.79 770.44 57.98 41.55 14.31 14.27 14.93 13.42 13.417
P/OCF 27.97 20.62 21.74 23.32 22.35 18.64 18.62 25.14 17.99 20.66 28.60 15.77 127.10 40.66 31.37 13.50 13.65 14.31 12.83 12.834
EV/EBITDA 36.70 20.01 22.20 24.28 21.15 19.87 24.78 22.46 17.07 13.60 11.51 8.43 21.80 25.57 28.23 24.30 8.43 8.90 9.50 8.53 8.528
EV/Revenue 6.23 4.65 4.68 4.95 4.42 3.79 4.38 3.78 3.09 2.73 2.86 2.48 2.49 2.29 2.72 2.24 2.49 3.11 3.25 2.98 2.976
EV/EBIT 41.61 21.82 24.44 26.84 23.24 22.12 27.95 25.55 19.34 15.27 12.64 9.13 27.17 33.73 36.13 31.17 9.03 9.41 10.03 8.98 8.983
EV/FCF 37.67 24.90 24.61 25.28 22.09 17.78 16.66 23.37 15.55 17.44 23.56 11.79 -68.86 555.12 48.99 34.23 12.08 12.50 12.34 11.00 10.997
Earnings Yield 1.8% 3.5% 5.8% 5.3% 5.6% 5.9% 1.9% 2.0% 2.6% 3.3% 4.2% 5.8% 0.7% 0.3% 0.2% 0.2% 6.4% 7.0% 6.4% 7.4% 7.35%
FCF Yield 2.4% 3.6% 3.5% 3.4% 3.9% 4.8% 4.9% 3.4% 5.0% 4.3% 3.2% 6.1% -1.1% 0.1% 1.7% 2.4% 7.0% 7.0% 6.7% 7.5% 7.45%
PEG Ratio snapshot only 0.007
Price/Tangible Book snapshot only 3.959
EV/OCF snapshot only 10.519
EV/Gross Profit snapshot only 3.229
Acquirers Multiple snapshot only 10.910
Shareholder Yield snapshot only 0.13%
Graham Number snapshot only $62.38
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.74 3.74 3.65 3.65 3.65 3.65 3.54 3.54 3.54 3.54 3.75 3.75 3.75 3.75 1.97 1.97 1.97 1.97 3.32 3.32 3.316
Quick Ratio 3.71 3.71 3.62 3.62 3.62 3.62 3.50 3.50 3.50 3.50 3.69 3.69 3.69 3.69 1.94 1.94 1.94 1.94 3.25 3.25 3.249
Debt/Equity 0.02 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.013
Net Debt/Equity -0.67 -0.67 -0.61 -0.61 -0.61 -0.61 -0.73 -0.73 -0.73 -0.73 -0.70 -0.70 -0.70 -0.70 -0.61 -0.61 -0.61 -0.61 -0.68 -0.68 -0.679
Debt/Assets 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.010
Debt/EBITDA 0.10 0.07 0.07 0.07 0.06 0.07 0.07 0.07 0.07 0.06 0.04 0.03 0.09 0.10 0.11 0.11 0.03 0.03 0.04 0.04 0.037
Net Debt/EBITDA -3.80 -2.59 -3.66 -3.63 -3.32 -3.62 -5.33 -5.48 -5.03 -4.41 -3.93 -3.27 -8.21 -9.92 -5.18 -5.20 -1.56 -1.26 -1.99 -1.88 -1.877
Interest Coverage 241.11 391.48 299.97 257.46 247.92 207.66 199.47 208.92 230.71 267.72 328.01 406.46 140.67 103.76 139.87 126.36 516.92 702.21 686.52 760.03 760.033
Equity Multiplier 1.36 1.36 1.31 1.31 1.31 1.31 1.34 1.34 1.34 1.34 1.31 1.31 1.31 1.31 1.58 1.58 1.58 1.58 1.35 1.35 1.346
Cash Ratio snapshot only 2.363
Debt Service Coverage snapshot only 800.567
Cash to Debt snapshot only 51.573
FCF to Debt snapshot only 20.898
Defensive Interval snapshot only 483.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.78 0.83 0.70 0.73 0.78 0.78 0.63 0.64 0.65 0.67 0.59 0.60 0.61 0.65 0.69 0.72 0.75 0.79 0.83 0.86 0.865
Inventory Turnover 12.27 12.79 8.45 9.17 9.83 10.59 7.25 7.74 8.34 8.62 6.00 6.13 6.32 6.83 6.20 6.40 6.45 6.39 5.07 5.26 5.256
Receivables Turnover 6.88 7.37 5.44 5.67 6.05 6.07 5.38 5.50 5.57 5.72 5.32 5.43 5.56 5.87 5.31 5.53 5.74 6.03 5.48 5.71 5.711
Payables Turnover 1.87 1.95 1.38 1.50 1.61 1.73 1.13 1.20 1.30 1.34 1.63 1.66 1.71 1.85 2.46 2.54 2.56 2.54 1.99 2.06 2.063
DSO 53 50 67 64 60 60 68 66 66 64 69 67 66 62 69 66 64 61 67 64 63.9 days
DIO 30 29 43 40 37 34 50 47 44 42 61 60 58 53 59 57 57 57 72 69 69.4 days
DPO 195 187 264 243 227 211 324 304 281 272 224 220 213 197 148 144 143 144 183 177 176.9 days
Cash Conversion Cycle -112 -109 -154 -139 -129 -116 -206 -190 -172 -166 -95 -93 -90 -82 -21 -21 -23 -26 -45 -44 -43.5 days
Fixed Asset Turnover snapshot only 7.069
Operating Cycle snapshot only 133.4 days
Cash Velocity snapshot only 1.497
Capital Intensity snapshot only 1.298
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 13.9% 18.6% 12.0% 15.2% 22.1% 14.3% 13.7% 11.4% 5.8% 8.4% 8.9% 8.6% 9.8% 12.9% 14.8% 17.1% 18.9% 18.1% 21.2% 21.5% 21.48%
Net Income 2.8% 2.6% 4.2% 95.0% 1.8% 63.9% -64.1% -65.2% -61.2% -51.5% 75.4% 1.3% -73.5% -92.4% -94.5% -97.1% 8.0% 35.6% 38.4% 66.3% 66.31%
EPS 2.8% 2.6% 4.2% 94.1% 1.8% 62.5% -64.5% -65.6% -61.6% -51.9% 74.4% 1.3% -72.5% -91.2% -93.7% -96.7% 8.8% 34.6% 37.0% 63.5% 63.50%
FCF 5.2% 3.0% 2.8% 7.1% 47.8% 30.8% 56.9% -7.9% 4.9% -20.4% -49.7% 41.0% -1.2% -97.0% -47.6% -63.5% 7.8% 70.2% 4.8% 4.0% 4.02%
EBITDA 7.8% 4.1% 4.5% 6.5% 50.4% -6.0% -4.8% -8.0% -8.5% 14.1% 53.3% 89.6% -30.6% -49.7% -55.6% -63.2% 2.1% 3.6% 3.3% 3.6% 3.60%
Op. Income 3.7% 3.5% 4.0% 16.1% 62.3% -8.6% -6.0% -22.9% -41.4% -13.8% 8.7% 42.1% -92.4% -1.0% -87.7% -71.0% 28.5% 105.9% 15.9% 6.1% 6.08%
OCF Growth snapshot only 2.96%
Asset Growth snapshot only 27.80%
Equity Growth snapshot only 49.89%
Debt Growth snapshot only 59.44%
Shares Change snapshot only 4.36%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 16.3% 17.5% 16.6% 16.0% 18.3% 16.5% 16.3% 15.9% 13.7% 13.7% 11.5% 11.7% 12.3% 11.8% 12.4% 12.3% 11.4% 13.1% 14.8% 15.6% 15.60%
Revenue 5Y 23.6% 23.3% 22.0% 20.5% 20.5% 18.6% 17.2% 17.7% 15.2% 15.0% 14.5% 13.5% 14.0% 14.1% 14.5% 14.6% 13.9% 14.4% 14.0% 14.7% 14.68%
EPS 3Y 1.0% 53.1% 44.3% 28.1% -9.5% 15.0% -33.5% -59.0% -66.2% -70.5% 1.2% 14.7% 60.7% 68.9% 68.85%
EPS 5Y 31.7% 25.4% 51.6% 39.1% 23.0% -20.5% -38.3% -39.5% 26.3% 26.27%
Net Income 3Y 1.1% 54.5% 45.6% 29.3% -8.7% 15.9% -33.9% -60.7% -67.5% -71.6% -2.7% 10.7% 55.7% 64.0% 64.04%
Net Income 5Y 35.4% 28.8% 55.5% 40.4% 24.1% -20.5% -39.6% -40.8% 24.5% 24.51%
EBITDA 3Y 54.2% 26.1% 23.2% 9.2% 3.4% 22.9% -1.5% -18.6% -13.5% -13.8% 25.0% 38.3% 43.2% 47.5% 47.46%
EBITDA 5Y 26.1% 24.5% 26.4% 39.9% 28.4% 3.5% -5.7% -5.6% 25.7% 25.72%
Gross Profit 3Y 16.5% 17.7% 16.9% 16.0% 18.4% 16.4% 16.0% 15.5% 13.0% 12.9% 10.5% 10.7% 11.4% 10.8% 11.3% 11.4% 10.6% 12.6% 14.7% 15.6% 15.58%
Gross Profit 5Y 23.0% 22.9% 21.9% 20.6% 20.8% 18.8% 17.1% 17.6% 14.9% 14.6% 14.0% 13.1% 13.5% 13.6% 13.9% 14.1% 13.4% 14.0% 13.6% 14.2% 14.24%
Op. Income 3Y 60.1% 29.9% 34.4% 14.9% 12.4% 8.4% -58.3% -49.9% -31.8% 9.6% 26.5% 31.2% 42.9% 42.87%
Op. Income 5Y 26.2% 31.2% 31.8% 33.2% 19.2% -35.9% -28.3% 21.2% 21.16%
FCF 3Y 82.3% 29.3% 15.8% 11.8% 6.5% 12.1% 11.6% -68.6% -25.5% -22.0% 12.5% 19.0% 14.9% 37.3% 37.28%
FCF 5Y 39.6% 26.3% 25.2% 68.6% 44.6% 11.3% 15.1% -50.9% -18.0% 20.6% 20.60%
OCF 3Y 2.4% 65.6% 30.6% 17.2% 8.7% 6.5% 10.9% 2.4% -48.4% -23.5% -20.4% 9.7% 16.0% 13.4% 32.7% 32.73%
OCF 5Y 28.2% 21.5% 19.7% 86.6% 41.8% 54.6% 44.9% 1.1% 31.1% 8.1% 11.7% -31.2% -13.9% 14.7% 14.67%
Assets 3Y 15.6% 15.6% 23.1% 23.1% 23.1% 23.1% 19.5% 19.5% 19.5% 19.5% 24.0% 24.0% 24.0% 24.0% 3.3% 3.3% 3.3% 3.3% 6.0% 6.0% 6.01%
Assets 5Y 28.7% 28.7% 24.7% 24.7% 24.7% 24.7% 20.5% 20.5% 20.5% 20.5% 20.7% 20.7% 20.7% 20.7% 9.7% 9.7% 9.7% 9.7% 14.3% 14.3% 14.34%
Equity 3Y 17.0% 17.0% 25.1% 25.1% 25.1% 25.1% 18.9% 18.9% 18.9% 18.9% 25.7% 25.7% 25.7% 25.7% -2.9% -2.9% -2.9% -2.9% 5.7% 5.7% 5.75%
Book Value 3Y 15.7% 15.9% 24.0% 24.0% 23.9% 23.9% 17.8% 17.3% 18.0% 17.6% 24.8% 24.7% 26.5% 31.1% 0.9% 0.9% 1.0% 0.6% 9.1% 8.9% 8.85%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 1.00 1.00 1.00 0.99 0.99 1.00 0.99 1.00 0.98 1.00 1.00 1.00 0.98 1.00 1.00 0.99 0.97 0.98 0.95 0.94 0.944
Earnings Stability 0.14 0.09 0.27 0.52 0.60 0.51 0.31 0.38 0.40 0.36 0.18 0.35 0.03 0.01 0.00 0.06 0.24 0.30 0.25 0.07 0.070
Margin Stability 0.99 0.99 1.00 1.00 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.99 0.988
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1
Earnings Persistence 0.20 0.20 0.20 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.500
Earnings Smoothness 0.36 0.05 0.52 0.06 0.03 0.12 0.31 0.45 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
ROE Trend 0.09 0.16 0.22 0.23 0.22 0.19 0.01 -0.14 -0.11 -0.12 -0.05 -0.02 -0.15 -0.16 -0.09 -0.10 0.20 0.29 0.19 0.20 0.202
Gross Margin Trend 0.00 0.00 0.00 -0.00 -0.00 -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 0.00 0.01 0.01 0.008
FCF Margin Trend 0.07 0.10 0.10 0.14 0.14 0.17 0.23 -0.04 0.02 -0.04 -0.11 0.03 -0.24 -0.18 -0.14 -0.12 0.13 0.17 0.18 0.13 0.133
Sustainable Growth Rate 13.0% 20.5% 29.7% 29.2% 29.6% 27.5% 8.4% 8.0% 9.0% 10.4% 12.5% 15.6% 2.0% 0.7% 0.8% 0.5% 20.2% 27.5% 29.9% 33.2% 33.24%
Internal Growth Rate 10.7% 18.1% 28.8% 28.2% 28.6% 26.0% 6.8% 6.4% 7.3% 8.6% 10.5% 13.4% 1.6% 0.5% 0.5% 0.3% 16.6% 24.1% 26.2% 30.0% 30.02%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.98 1.39 0.79 0.81 0.80 0.92 2.85 2.00 2.13 1.49 0.83 1.10 -0.63 3.14 10.28 17.99 1.15 1.05 1.10 1.06 1.059
FCF/OCF 0.67 0.73 0.76 0.80 0.87 0.89 0.92 0.86 0.89 0.89 0.90 0.96 2.28 0.16 0.70 0.75 0.94 0.96 0.96 0.96 0.957
FCF/Net Income snapshot only 1.013
OCF/EBITDA snapshot only 0.811
CapEx/Revenue 8.0% 6.8% 6.1% 4.8% 2.9% 2.7% 2.3% 2.5% 2.4% 1.8% 1.3% 0.8% 2.0% 2.1% 2.4% 2.1% 1.3% 1.1% 1.1% 1.2% 1.23%
CapEx/Depreciation snapshot only 0.696
Accruals Ratio -0.09 -0.06 0.05 0.04 0.04 0.02 -0.12 -0.06 -0.08 -0.04 0.02 -0.01 0.03 -0.01 -0.05 -0.06 -0.02 -0.01 -0.02 -0.01 -0.014
Sloan Accruals snapshot only 0.293
Cash Flow Adequacy snapshot only 23.017
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 1.6% 1.6% 1.3% 6.0% 4.2% 3.4% 20.9% 61.7% 61.5% 94.3% 2.2% 1.6% 1.5% 1.8% 1.81%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.2% 0.2% 0.2% 15.3% 15.5% 14.7% 16.7% 0.1% 0.1% 0.1% 0.1% 0.13%
Net Buyback Yield -0.3% -0.2% -0.4% -0.3% -0.4% -0.5% -0.3% -0.3% -0.2% -0.1% 0.0% 0.1% 15.3% 15.4% 0.0% -0.0% -14.8% -12.0% -1.0% -1.5% -1.49%
Total Shareholder Return -0.3% -0.2% -0.4% -0.3% -0.4% -0.5% -0.3% -0.3% -0.2% -0.1% 0.0% 0.1% 15.3% 15.4% 0.0% -0.0% -14.8% -12.0% -1.0% -1.5% -1.49%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.83 0.86 1.66 1.63 1.50 1.54 0.64 0.64 0.66 0.66 0.72 0.73 0.28 0.12 0.10 0.07 0.69 0.75 0.77 0.81 0.807
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 0.99 1.00 1.00 1.00 1.00 1.00 0.99 0.99 0.99 0.99 1.00 1.00 1.00 1.00 0.999
EBIT Margin 0.15 0.21 0.19 0.18 0.19 0.17 0.16 0.15 0.16 0.18 0.23 0.27 0.09 0.07 0.08 0.07 0.28 0.33 0.32 0.33 0.331
Asset Turnover 0.78 0.83 0.70 0.73 0.78 0.78 0.63 0.64 0.65 0.67 0.59 0.60 0.61 0.65 0.69 0.72 0.75 0.79 0.83 0.86 0.865
Equity Multiplier 1.34 1.34 1.33 1.33 1.33 1.33 1.32 1.32 1.32 1.32 1.32 1.32 1.32 1.32 1.42 1.42 1.42 1.42 1.44 1.44 1.440
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $1.52 $2.41 $4.27 $4.18 $4.23 $3.91 $1.52 $1.44 $1.62 $1.88 $2.64 $3.28 $0.45 $0.17 $0.17 $0.11 $4.38 $5.90 $6.28 $6.92 $6.92
Book Value/Share $11.75 $11.75 $16.98 $16.91 $16.86 $16.82 $19.44 $19.37 $19.37 $19.32 $22.95 $22.84 $23.79 $26.50 $17.46 $17.39 $17.35 $17.12 $25.24 $24.98 $27.85
Tangible Book/Share $10.27 $10.27 $15.60 $15.54 $15.49 $15.45 $18.17 $18.11 $18.10 $18.06 $21.72 $21.61 $22.51 $25.08 $16.10 $16.04 $15.99 $15.78 $24.01 $23.77 $23.77
Revenue/Share $12.24 $13.11 $13.45 $13.97 $14.85 $14.86 $15.10 $15.38 $15.57 $15.96 $16.34 $16.58 $17.68 $20.81 $21.48 $22.27 $23.07 $23.89 $25.11 $25.92 $26.89
FCF/Share $2.02 $2.45 $2.56 $2.73 $2.97 $3.17 $3.97 $2.49 $3.09 $2.50 $1.99 $3.48 $-0.64 $0.09 $1.19 $1.46 $4.76 $5.94 $6.62 $7.01 $7.28
OCF/Share $3.01 $3.34 $3.38 $3.40 $3.40 $3.58 $4.31 $2.88 $3.46 $2.80 $2.20 $3.61 $-0.28 $0.52 $1.70 $1.93 $5.05 $6.21 $6.90 $7.33 $7.61
Cash/Share $8.11 $8.11 $10.58 $10.53 $10.50 $10.47 $14.41 $14.36 $14.35 $14.32 $16.17 $16.09 $16.76 $18.67 $10.93 $10.89 $10.86 $10.71 $17.49 $17.31 $20.15
EBITDA/Share $2.08 $3.04 $2.84 $2.85 $3.10 $2.84 $2.67 $2.59 $2.82 $3.21 $4.07 $4.87 $2.02 $1.86 $2.07 $2.05 $6.82 $8.35 $8.60 $9.05 $9.05
Debt/Share $0.21 $0.21 $0.20 $0.20 $0.20 $0.20 $0.18 $0.18 $0.18 $0.18 $0.17 $0.17 $0.18 $0.20 $0.22 $0.22 $0.22 $0.22 $0.34 $0.34 $0.34
Net Debt/Share $-7.89 $-7.89 $-10.38 $-10.33 $-10.30 $-10.27 $-14.22 $-14.17 $-14.17 $-14.14 $-16.00 $-15.92 $-16.58 $-18.47 $-10.71 $-10.67 $-10.64 $-10.50 $-17.15 $-16.98 $-16.98
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 8.738
Altman Z-Prime snapshot only 16.458
Piotroski F-Score 6 7 4 4 5 4 5 5 4 4 6 7 5 7 5 6 7 6 8 8 8
Beneish M-Score -2.43 -2.29 -1.89 -1.90 -1.89 -2.02 -2.99 -2.79 -2.81 -2.62 -2.15 -2.25 -2.11 -2.24 -2.56 -2.60 -2.43 -2.36 -2.44 -2.41 -2.407
Ohlson O-Score snapshot only -12.212
ROIC (Greenblatt) snapshot only 41.63%
Net-Net WC snapshot only $15.57
EVA snapshot only $1014813117.38
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AAA
Credit Score 97.04 97.01 96.92 96.90 97.16 97.14 97.45 96.86 97.09 96.90 96.85 96.75 90.26 99.36 97.06 96.93 96.91 96.55 96.88 96.76 96.760
Credit Grade snapshot only 1
Credit Trend snapshot only -0.169
Implied Spread (bps) snapshot only 50.000
Industry Credit Rank snapshot only 95
Sector Credit Rank snapshot only 92

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms